Matthew W. Johnson(@Drug_Researcher) 's Twitter Profileg
Matthew W. Johnson

@Drug_Researcher

Psychedelic scientist @ Sheppard Pratt. Conducted seminal psychedelic research for 20 years at Hopkins. Expertise in many drugs, behavioral economics, addiction

ID:883019018436845570

linkhttp://www.hopkinsmedicine.org/profiles/results/directory/profile/0800020/matthew-johnson?pagecount= calendar_today06-07-2017 17:45:14

2,1K Tweets

31,6K Followers

557 Following

SOCIETAL MEDIA(@SOCIETAL_MEDIA) 's Twitter Profile Photo

Matthew W. Johnson Lex Fridman We're working on a series of conversations centered around with Ed Prideaux, a writer and psychedelic researcher. You can watch a brief clip here x.com/SOCIETAL_MEDIA… and follow us for more on this topic.

account_circle
Matthew W. Johnson(@Drug_Researcher) 's Twitter Profile Photo

Excellent description of HPPD from psychedelics, as experienced by the fascinating journalist Andrew Callaghan, interviewed by Lex Fridman . We will no doubt see HPPD cases with medical psychedelics. Likely rare but a real risk. It needs more attention. youtu.be/DwE52PDPfEE?fe…

account_circle
Matthew W. Johnson(@Drug_Researcher) 's Twitter Profile Photo

Good for Cornell! Universities need to finally grow some guts & protect diversity of thought & the principles of a liberal, tolerant society. Don't give in to mobs who threaten violence or disrupt the rights of others to assemble & communicate. Enough with the intolerance!

account_circle
Matthew W. Johnson(@Drug_Researcher) 's Twitter Profile Photo

Looking forward to presenting on the psychedelic medicine paradigm this Friday at the Center for Neuroscience & Behavior at American University, along with several great colleagues. Looks like virtual attendance is an option.
american.edu/research/sympo…

account_circle
Matthew W. Johnson(@Drug_Researcher) 's Twitter Profile Photo

There is negligible recreational use of these compounds or public health harm. It's important that we not overly restrict these research tools. A schedule 1 license is a very high bar. Unnecessary scheduling of DOI & DOC will stall serotonin research & mental health research.

account_circle
Matthew W. Johnson(@Drug_Researcher) 's Twitter Profile Photo

I wonder if there will be challenges to patenting the ability to communicate with extra-dimensional entities with psychedelics. Is there prior art that is being ignored with all the DMT accounts? But I have to say, it's an absolutely perfect day for making such an announcement.

account_circle
Matthew W. Johnson(@Drug_Researcher) 's Twitter Profile Photo

Was great to present with Franklin King MD & other expert colleagues for the MA legislature on psychedelics. One of the most important roles for a scientist. Done so for NJ, VA, MD & Capitil Hill over the years. Glad the paper inspired a talented scientist & clinician. I'm lucky.

account_circle
Matthew W. Johnson(@Drug_Researcher) 's Twitter Profile Photo

Please spread the word & participate. This is a very creative collaboration among scientists & journalists addressing important questions about your experience of media regarding psychedelics.

account_circle
Brad J. Whittaker(@bradjwhittaker) 's Twitter Profile Photo

Matthew W. Johnson Have you used psilocybin/ magic mushrooms before? Volunteers wanted for a 10-minute online study: Motives for using psilocybin/magic mushrooms and self-identity. To participate please use the below link: livpsych.eu.qualtrics.com/jfe/form/SV_b4…

account_circle
Max Wolff(@trpwolff) 's Twitter Profile Photo

Great news! The MEQ and CEQ are relatively long questionnaires. These new shorter versions make space in psychometric batteries for scales that focus on other important aspects of study participants' experiences.

account_circle